SMARCB1 and rhabdoid tumor: Eleven patients were re-classified as having rhabdoid tumors on CHIC retrospective consensus review (including one patient previously confirmed by author MF) [7], with confirmed loss of SMARCB1 expression by INI1 immunohistochemistry in 10 of the patients (Table 1).